Ophthalmology Education and CME

Select a Specialty

Optimizing Strategies for Topical Management of Glaucoma: Treatment Options and Improving Adherence

Because glaucoma typically begins by affecting the far periphery of the vision, most patients are unaware that they have the disease until it progresses and destroys…

go to activity »
Case Presentation: CyPass Stent in the Left Eye and an iStent in the Right Eye
CME

Case Presentation: CyPass Stent in the Left Eye and an iStent in the Right Eye

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 1/5/2019
Credit Type(s): CME | Credit: 0.25

In this CME activity, the clinical course of a patient with a CyPass Stent in the left eye and an iStent in the right eye will be described….

go to activity »
Cataract & Refractive 360: Fundamentals, Techniques, & Technology; Volume 2, Number 4
CME

Cataract & Refractive 360: Fundamentals, Techniques, & Technology; Volume 2, Number 4

This activity is supported by educational grants from Abbott Medical Optics, Inc., Alcon Laboratories, Inc., and Carl Zeiss Meditec, Inc.

Expiration Date: 11/9/2018
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, which…

go to activity »
Uveitis 101 for Busy Retina Specialists  Case Discussions: Medical and Surgical Approaches in Managing Patients With Uveitis
CME

Uveitis 101 for Busy Retina Specialists

Case Discussions: Medical and Surgical Approaches in Managing Patients With Uveitis

Expiration Date: 12/31/2018
Credit Type(s): AMA PRA Category 1 CreditTM | Credit: 1.5

This activity presents an update on differential diagnosis of noninfectious uveitis of the posterior segment (NIU-PS) and current and emerging treatments for patients…

go to activity »
Medical Management of Glaucoma: Recent Approvals and Drugs Under Investigation
CME

Medical Management of Glaucoma: Recent Approvals and Drugs Under Investigation

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 12/19/2018
Credit Type(s): CME | Credit: 0.5

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the condition. This activity will evaluate clinical…

go to activity »
Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 4
CMECOPE

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 4

This activity is supported by an educational grant from Shire.

Expiration Date: 11/30/2018
Credit Type(s): CME / COPE | Credit: 1.25

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently…

go to activity »
The Coming of Age of Early to Late Age-Related Macular Degeneration: Classification and Treatment
CME

The Coming of Age of Early to Late Age-Related Macular Degeneration: Classification and Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 1/15/2019
Credit Type(s): CME | Credit: 0.75

Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), affects approximately 5 million individuals worldwide. Advances in predictive and…

go to activity »
Genetic Testing for Inherited Retinal Diseases in Ophthalmology: What Do Clinicians Need to Know?
CME

Genetic Testing for Inherited Retinal Diseases in Ophthalmology: What Do Clinicians Need to Know?

Expiration Date: 12/23/2018
Credit Type(s): CME | Credit: 0.5

The landscape of genetic testing and treatment for inherited retinal diseases (IRDs) is rapidly evolving. Keeping up-to-date on clinical trials, ordering and…

go to activity »
Innovative Targeting of IOP, Emerging New Science in Glaucoma Management
CME

Innovative Targeting of IOP, Emerging New Science in Glaucoma Management

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 12/26/2018
Credit Type(s): CME | Credit: 1

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the condition. With the aging population, it is…

go to activity »
Putting Dry Eye in Focus: Clinical Case Discussions
CME

Putting Dry Eye in Focus: Clinical Case Discussions

This educational activity is supported by an independent medical educational grant from Shire.

Expiration Date: 12/20/2018
Credit Type(s): CME | Credit: 1

Dry eye disease (DED) is a multifactorial disorder of the ocular surface, with nearly 30 million adults in the United States reporting symptoms. Despite its high…

go to activity »
Surgical Glaucoma Update
CME

Surgical Glaucoma Update

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 12/19/2018
Credit Type(s): CME | Credit: 0.5

Incisional glaucoma surgery has traditionally been reserved for patients with progressive disease, and in whom medical and laser therapies have been exhausted…

go to activity »
Cataract and Refractive 360 – Fundamentals, Techniques, and Technology: Volume 2, Number 3
CME

Cataract and Refractive 360 – Fundamentals, Techniques, and Technology: Volume 2, Number 3

This activity is supported by educational grants from Abbott Medical Optics, Inc.; Alcon Laboratories, Inc.; and Carl Zeiss Meditec, Inc.

Expiration Date: 10/9/2018
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, which…

go to activity »